Promoting Medication Adherence Among Older Adults With Hypertension
NCT ID: NCT02846220
Last Updated: 2020-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2016-10-31
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As a critical step in testing this intervention to target these 'hidden motives', the investigators will undertake a pilot study to assess the feasibility and acceptability of the Overcoming Immunity-to-Change intervention and determine effect sizes of the intervention on adherence, blood pressure (BP) control, and quality of life (QOL). The investigators will test the Immunity-to-Change intervention in a sample of nonadherent older adults with hypertension (n=18). Another sample of nonadherent older adults with hypertension will be monitored for comparison (n=18).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telehealth & Remote Measurement Technologies to Improve Medication Adherence in Hypertension
NCT01439256
Medication Adherence in Hypertension Study
NCT00688350
Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness Practice
NCT03924531
Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
NCT00201201
Patient-Physician Partnership to Improve High Blood Pressure Adherence
NCT00123045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health coaching
Two-hour in-person group counseling session led by health coach, involving development of personalized immunity maps that lay out adherence goal, behaviors that distract from goal, hidden motives that compete with achieving goal, and underlying assumptions
Eight 50-minute individual telephone counseling sessions every three weeks with a health coach, focusing on uncovering hidden motives and challenging assumptions with the goal of overturning nonadherence mindsets
Overcoming Immunity to Change health coaching
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Overcoming Immunity to Change health coaching
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of essential hypertension
* Uncontrolled hypertension
* Current treatment with antihypertensive medication
* Low antihypertensive pharmacy refill
* English speaking
* Telephone access
* Ability to read print on a computer screen and use the computer keyboard
* Written consent to participate and HIPAA authorization
* Written acceptance of study contract
* Approval of health care provider
Exclusion Criteria
* Enrollment in another clinical trial
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minds at Work
UNKNOWN
Ohio State University
OTHER
Tulane University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie Krousel-Wood
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie A Krousel-Wood, MD MSPH
Role: PRINCIPAL_INVESTIGATOR
Tulane University
Erin M Peacock, PhD MPH
Role: STUDY_DIRECTOR
Tulane University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tulane University
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Krousel-Wood M, Kegan R, Whelton PK, Lahey LL. Immunity-to-change: are hidden motives underlying patient nonadherence to chronic disease medications? Am J Med Sci. 2014 Aug;348(2):121-8. doi: 10.1097/MAJ.0000000000000310.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
735133
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.